Cargando…
Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
Discriminating between malignant pleural effusion (MPE) and benign pleural effusion (BPE) remains difficult. Thus, novel and efficient biomarkers are required for the diagnosis of pleural effusion (PE). The aim of this study was to validate calprotectin as a diagnostic biomarker of PE in clinical se...
Autores principales: | Botana-Rial, Maribel, Vázquez-Iglesias, Lorena, Casado-Rey, Pedro, Cadena, María Páez de la, Andrade-Olivié, María Amalia, Abal-Arca, José, García-Nimo, Laura, Ferreiro-Fernández, Lucía, Valdés-Cuadrado, Luis, San-José, María Esther, Rodríguez-Berrocal, Francisco Javier, Fernández-Villar, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105479/ https://www.ncbi.nlm.nih.gov/pubmed/32231227 http://dx.doi.org/10.1038/s41598-020-62388-y |
Ejemplares similares
-
A rapid calprotectin test for the diagnosis of pleural effusion
por: Casado-Rey, Pedro, et al.
Publicado: (2021) -
Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012) -
Management of malignant pleural effusion by an indwelling pleural catheter: A cost-efficiency analysis
por: Rial, Maribel Botana, et al.
Publicado: (2015) -
Levels of PEDF in Pleural Effusions from Lung Adenocarcinoma and Benign Disease Patients
por: Sánchez-Otero, Nuria, et al.
Publicado: (2013) -
Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
por: Blanco-Prieto, Sonia, et al.
Publicado: (2015)